Sygnature takes immense pride in its numerous accomplishments, fruitful research partnerships, and well-deserved awards. It is with great pleasure that we share these remarkable achievements at every available opportunity. Contained herein, you will have the opportunity to explore and be informed about the latest and most thrilling advancements taking place within our organization.
Filter by:
31st July 2023
News
Sygnature Discovery accelerates global growth with major North American acquisition
12th June 2023
News
Sygnature Discovery launches its in vivo LPS model to profile early-stage anti-inflammatory drugs
18th April 2023
News
Sygnature Discovery and Daewoong Pharma announce research collaboration
7th March 2023
News
New platform set to accelerate early-stage targeted protein degradation
17th January 2023
News
Sygnature Discovery completes acquisition of SB Drug Discovery to further strengthen its market-leading capabilities
22nd December 2022
News
Sygnature Discovery partners the Oncology Development Programme (ODP2) to find UK-based breakthroughs in Oncology
10th May 2022
News
Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’
26th April 2022
News
Sygnature Discovery acquires Peak Proteins
24th March 2022
News
500 – and counting!
11th February 2022
News
Taking a 3D view of heart failure with River BioMedics
13th January 2022
News
Our new Chairman: Dr Charles Woler
7th January 2022
News
Sygnature strengthens with MedChemica software solution